310 results on '"Chegou, Novel N"'
Search Results
2. Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis
3. Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)
4. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
5. Newborn bacille Calmette-Guérin vaccination induces robust infant interferon-γ-expressing natural killer cell responses to mycobacteria
6. Evaluation of host biomarkers for monitoring treatment response in spinal tuberculosis: A 12-month cohort study
7. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis
8. Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis
9. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis: A preliminary biomarker discovery study
10. Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study
11. Mycobacterium tuberculosis-stimulated whole blood culture to detect host biosignatures for tuberculosis treatment response
12. Host urine immunological biomarkers as potential candidates for the diagnosis of tuberculosis
13. PA-511 Utility of host transcriptomic biomarkers in the diagnosis of spinal tuberculosis
14. PA-347 Diagnostic accuracy of published host blood transcriptomic tuberculosis signatures in a low burden hospital setting
15. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
16. Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
17. Diagnostic performance of host protein signatures as a triage test for active pulmonary TB
18. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
19. Host blood RNA signatures predict the outcome of tuberculosis treatment
20. Serum biomarkers for monitoring response to tuberculosis treatment: an assessment of the effect of different covariates among slow and fast treatment responders.
21. Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa
22. Editorial: Immuno-diagnosis of active tuberculosis; are we making progress?
23. An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota
24. Newborn BCG vaccination induces robust infant IFNγ-expressing NK cell responses to mycobacteria
25. Diagnostic Performance of Host Blood Transcriptomic Signatures for Pulmonary Tuberculosis in a Multi-Cohort Study of Symptomatic Patients in Africa
26. Differential expression of host protein biomarkers among symptomatic clinic attendees finally diagnosed with tuberculosis and other respiratory diseases with or without latent Mycobacterium tuberculosis infection
27. Host Immune Response to Tuberculous Meningitis
28. Increased Interferon-Induced Protein With Tetracopeptides (IFITs) Reduces Mycobacterial Growth
29. CXCL13, CXCL10 and CXCL8 as Indicators of Ocular and Neurological Involvement in Patients With Ocular Syphilis: An Observational Descriptive Study
30. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis
31. Validation of host cerebrospinal fluid protein biomarkers for early diagnosis of tuberculous meningitis in children: a replication and new biosignature discovery study
32. Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL): A cross-sectional observational study protocol using respondent driven sampling
33. Comparison of Cytokines Expression from Human Monocyte-Derived Macrophages Infected with Different Species of Mycobacteria
34. The Intestinal Commensal, Bacteroides fragilis, Modulates Host Responses to Viral Infection and Therapy: Lessons for Exploration during Mycobacterium tuberculosis Infection
35. Host biomarkers detected in saliva show promise as markers for the diagnosis of pulmonary tuberculosis disease and monitoring of the response to tuberculosis treatment
36. Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting
37. CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries
38. Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis
39. The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination
40. Differential cytokine/chemokines and KL-6 profiles in patients with different forms of tuberculosis
41. Modulatory Effects of Oleanolic Acid on Cardiac Anti-Oxidant Status and Inflammatory Response in High Fructose-Fed Neonatal Sprague-Dawley Rats.
42. Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa
43. CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries
44. Bifunctional T-Cell-Derived Cytokines for the Diagnosis of Tuberculosis and Treatment Monitoring
45. Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis
46. Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa
47. Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
48. A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries
49. Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches
50. Newborn BCG Vaccination Induces Robust Infant IFN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.